Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-mechanism pre-surgical window trial of metformin in non-diabetic women with endometrial carcinoma
2011-001382-40Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in endometrial cancer (EC) and endometrial hyperplasia (EH), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Ki-67 expression by the tumour. Started Aug 2011; status: completed.
02
Drugs
metformin
03
Conditions
endometrial cancer (EC)endometrial hyperplasia (EH)
Beyond the preview
Go deeper on 2011-001382-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001382-40.